Randomized Study to Evaluate the Efficacy of Fluvastatin on Inflammatory Markers in Patients With Aortic Stenosis.

NCT00404287 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

164

Enrollment

OTHER

Sponsor class

Stopped Funding not enough to complete the study

Conditions

Aortic Valve Stenosis

Interventions

DRUG: Fluvastatin

Sponsor

AORTICA Group